Showing results (41-50 of 322) with videos related to
Sort By:
Pageof 33
Biotherapy (Dordrecht, Netherlands)|January 1, 1993
Augmentation of antitumor immunity in regional lymph nodes by local immunotherapyI Sakita, T Monden, H Nagaoka, et al.Biotherapy (Dordrecht, Netherlands)|January 1, 1993
Free versus liposome-encapsulated muramyl tripeptide phosphatidylethanolamide (MTPPE) and interferon-y (IFN-y) in experimental infection with Listeria monocytogenesP M Melissen, W van Vianen, O Bidjai, et al.Biotherapy (Dordrecht, Netherlands)|January 1, 1993
Prevention of doxorubicin-induced cardiotoxicity by recombinant interleukin-1 in hamsters. Doxorubicin cardiotoxicity and interleukin-1T Yoshida, H Okumura, H Kaya, et al.Biotherapy (Dordrecht, Netherlands)|January 1, 1993
The expression and biological activity of IL-2 receptor on a human pancreas cancer cell lineH Kawami, K Yoshida, Y Yamaguchi, et al.Biotherapy (Dordrecht, Netherlands)|January 1, 1991
The synergistic effects of gamma interferon and clofazimine on phagocyte function: restoration of inhibition due to a 25 kilodalton fraction from Mycobacterium tuberculosisR B Parak, A A WadeeBiotherapy (Dordrecht, Netherlands)|January 1, 1993
Pharmacokinetics and immunomodulatory effects on monocytes during prolonged therapy with liposomal muramyltripeptideR Landmann, R Obrist, H Denz, et al.Biotherapy (Dordrecht, Netherlands)|January 1, 1993
The effect of local immunotherapy for breast cancer using a mixture of OK-432 and fibrinogen supplemented with activated macrophagesT Takeda, T Kobayashi, T Monden, et al.Biotherapy (Dordrecht, Netherlands)|January 1, 1993
Tissue distribution and cellular distribution of liposomes encapsulating muramyltripeptide phosphatidyl ethanolamide. Tissue and cellular distribution of LE-MTPPEP M Melissen, W van Vianen, P J Leenen, et al.Biotherapy (Dordrecht, Netherlands)|January 1, 1992
Inhibition of proliferation of retrovirus-immortalized macrophages by LPS and IFN-gamma: possible autocrine down-regulation of cell growth by induction of IL1 and TNFE Ayroldi, E Blasi, L Varesio, et al.Biotherapy (Dordrecht, Netherlands)|January 1, 1992
Predictive indicators for the therapeutic effect of OK-432 in patients with chronic active type B hepatitisK Nishimura, S Ishizaka, T TsujiiPageof 33